Evidence map›Paper›PMID 26989010›Full record

ArticleNitric oxide : biology and chemistry2016

Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling.

Chunying Li, Michaella M Reif, Siobhan M Craige, Shashi Kant, John F Keaney

Open access · greenAbstract read
In one paragraph

Article in Nitric oxide : biology and chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. JNK and cardiometabolic dysfunction.Bioscience reports · 2019
    Review
  13. Article
  14. Endothelial Cell Aging: How miRNAs Contribute?Journal of clinical medicine · 2018
    Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chunying LiDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Michaella M ReifDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Siobhan M CraigeDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Shashi KantDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. Electronic address: shashi.kant@umassmed.edu.
John F KeaneyDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA. Electronic address: john.keaney@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

Nox4 and Vascular HomeostasisR01HL098407 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KEANEY, JOHN FRANCIS · 2010 to 2017
$3.8M
Mitochondrial Modulation of Endothelia FunctionR01HL092122 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KEANEY, JOHN FRANCIS · 2009 to 2016
$3.3M
NHLBI NIH HHS R01 HL092122NHLBI NIH HHS R01 HL098407
6 · The paper itself

Abstract

Metabolic stress sensors like AMP-activated protein kinase (AMPK) are known to confer stress adaptation and promote longevity in lower organisms. This study demonstrates that activating the metabolic stress sensor AMP-activated protein kinase (AMPK) in endothelial cells helps maintain normal cellular function by promoting mitochondrial biogenesis and stress adaptation. To better define the mechanisms whereby AMPK promotes endothelial stress resistance, we used 5-aminoimidazole-4-carboxamide riboside (AICAR) to chronically activate AMPK and observed stimulation of mitochondrial biogenesis in wild type mouse endothelium, but not in endothelium from endothelial nitric oxide synthase knockout (eNOS-null) mice. Interestingly, AICAR-enhanced mitochondrial biogenesis was blocked by pretreatment with the mammalian target of rapamycin complex 1 (mTORC1) inhibitor, rapamycin. Further, AICAR stimulated mTORC1 as determined by phosphorylation of its known downstream effectors in wild type, but not eNOS-null, endothelial cells. Together these data indicate that eNOS is needed to couple AMPK activation to mTORC1 and thus promote mitochondrial biogenesis and stress adaptation in the endothelium. These data suggest a novel mechanism for mTORC1 activation that is significant for investigations in vascular dysfunction.

Indexed as

Adaptation, PhysiologicalAminoimidazole CarboxamideAMP-Activated Protein KinasesAnimalsCalcimycinCells, CulturedEndothelial CellsEndothelium, VascularEnzyme ActivatorsHumansHydrogen PeroxideMechanistic Target of Rapamycin Complex 1Mice, KnockoutMitochondriaNitric Oxide Synthase Type IIIOrganelle BiogenesisAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesCalcimycinEnzyme ActivatorsHydrogen PeroxideMechanistic Target of Rapamycin Complex 1Nitric Oxide Synthase Type IIIRibonucleotidesSirolimusAICARAMPKEndothelial dysfunctioneNOSMitochondrial biogenesismTORC1Nitric oxideRapamycin

Identifiers

PMID26989010
PMCPMC4860108
OpenAlexW2299490336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.